{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T16:04:47Z","timestamp":1769184287687,"version":"3.49.0"},"reference-count":36,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2010,3,2]],"date-time":"2010-03-02T00:00:00Z","timestamp":1267488000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[2010,5]]},"abstract":"<jats:p><jats:bold>Background and purpose:\u2002<\/jats:bold>Due to their potent bronchodilator properties, \u03b2<jats:sub>2<\/jats:sub>\u2010adrenoceptor agonists are a mainstay of therapy in asthma. However, the effects of \u03b2<jats:sub>2<\/jats:sub>\u2010adrenoceptor agonists on inflammation are less clear. Accordingly, we have investigated the effects of \u03b2<jats:sub>2<\/jats:sub>\u2010adrenoceptor agonists on inflammatory mediator release.<\/jats:p><jats:p><jats:bold>Experimental approach:\u2002<\/jats:bold>Transcription factor activation, and both release and mRNA expression of IL\u20106 and IL\u20108 were examined by luciferase reporter assay,<jats:sc>elisa<\/jats:sc>and real\u2010time RT\u2013PCR in bronchial human epithelial BEAS\u20102B cells or primary human bronchial epithelial cells grown at an air\u2013liquid interface.<\/jats:p><jats:p><jats:bold>Key results:\u2002<\/jats:bold>Pre\u2010incubation with \u03b2<jats:sub>2<\/jats:sub>\u2010adrenoceptor agonists (salbutamol, salmeterol, formoterol) augmented the release and mRNA expression of IL\u20106 and IL\u20108 induced by IL\u20101\u03b2 and IL\u20101\u03b2 plus histamine, whereas NF\u2010\u03baB\u2010dependent transcription was significantly repressed, and AP\u20101\u2010dependent transcription was unaffected. These effects were mimicked by other cAMP\u2010elevating agents (PGE<jats:sub>2<\/jats:sub>, forskolin). Enhancement of cytokine release by \u03b2<jats:sub>2<\/jats:sub>\u2010adrenoceptor agonists also occurred in primary bronchial epithelial cells. Addition of dexamethasone with salmeterol repressed IL\u20106 and IL\u20108 release to levels that were similar to the repression achieved in the absence of salmeterol. IL\u20106 release was enhanced when salmeterol was added before, concurrently or after IL\u20101\u03b2 plus histamine stimulation, whereas IL\u20108 release was only enhanced by salmeterol addition prior to stimulation.<\/jats:p><jats:p><jats:bold>Conclusions and implications:\u2002<\/jats:bold>Enhancement of IL\u20106 and IL\u20108 release may contribute to the deleterious effects of \u03b2<jats:sub>2<\/jats:sub>\u2010adrenoceptor agonists in asthma. As increased inflammatory mediator expression is prevented by the addition of glucocorticoid to the \u03b2<jats:sub>2<\/jats:sub>\u2010adrenoceptor, our data provide further mechanistic support for the use of combination therapies in asthma management.<\/jats:p>","DOI":"10.1111\/j.1476-5381.2010.00708.x","type":"journal-article","created":{"date-parts":[[2010,3,2]],"date-time":"2010-03-02T11:11:46Z","timestamp":1267528306000},"page":"410-420","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Enhancement of inflammatory mediator release by \u03b2<sub>2<\/sub>\u2010adrenoceptor agonists in airway epithelial cells is reversed by glucocorticoid action"],"prefix":"10.1111","volume":"160","author":[{"given":"NS","family":"Holden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CF","family":"Rider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MJ","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Velayudhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"EM","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Salmon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MA","family":"Giembycz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Newton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,4,26]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2003.12.039"},{"issue":"1","key":"e_1_2_8_3_1","first-page":"S1","article-title":"Guide to Receptors and Channels (GRAC)","volume":"158","author":"Alexander SPH","year":"2009","journal-title":"Br J Pharmacol"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb.26.4.4681"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxh325"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00138707"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.18.4.2108"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.16-03-00919.1996"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M400765200"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.106.025841"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00313.2004"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)92505-1"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1357-2725(02)00048-1"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj3510095"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M701325200"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.2000.279.4.L675"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.06.00112605"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2007.05.224"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707457"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1513\/pats.200806-054RM"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.120.1.258"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.107.040121"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.060020"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.129.1.15"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.1.478"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-2536"},{"key":"e_1_2_8_27_1","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0022-3565(24)37973-X","article-title":"Pharmacological inhibition of protein kinases in intact cells: antagonism of beta adrenergic receptor ligand binding by H\u201089 reveals limitations of usefulness","volume":"288","author":"Penn RB","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1089\/107999099313866"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2004.07.003"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199411040-00005"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2003-0388OC"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-7435(78)90265-7"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2006.11.014"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2006.06.007"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2005-0048OC"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117266"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M310190200"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5381.2010.00708.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5381.2010.00708.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T22:53:08Z","timestamp":1739919188000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5381.2010.00708.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,26]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["10.1111\/j.1476-5381.2010.00708.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1476-5381.2010.00708.x","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,26]]},"assertion":[{"value":"2010-04-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}